SX-517 is a dual CXCR2/1 antagonist that inhibits CXCL-1-induced Ca²⁺ flux (IC₅₀ = 38 nM), antagonizes CXCL-8-induced [³⁵S]GTPγS binding (IC₅₀ = 60 nM), and suppresses ERK1/2 phosphorylation; it demonstrates significant anti-inflammatory activity in human polymorphonuclear cells (PMNs) and mouse models.